Five for Friday December 5: Celebrating Success in Advancing Medication Use Quality

Welcome to Five For Friday!

A research partnership between PQA, Merck, and the University of Mississippi focused on three PQA adherence measures to continue to monitor their impact. The project examined Medicare Advantage enrollees who were taking either diabetes, renin-angiotensin system antagonist, or statin medications.

The study found that higher proportion of days covered (PDC) in one year was associated with lower payer medical costs in the subsequent year. These findings further the bounty of evidence that suggests that better adherence is related to better outcomes. Learn more about the research project below.

We also highlight our members' perspectives on patient access, medication adherence and immunizations. If you have news you'd like for us to spotlight in an upcoming Five For Friday, send us an email!

-- Melissa Castora-Binkley, PhD, PQA Senior Director, Research

Teaming Up For Patient Access  

"Our industry is moving from transactional relationships to strategic alliances that can share risks and resources at the same time for long-term patient impact; therefore, access planning must begin earlier in the product lifecycle with multistakeholder engagement," said McKesson's Natalie Bedford. She shares insights from a recent NASP panel on how to combat growing patient access barriers with industrywide collaboration.

Addressing Medication Adherence    
Andrew Maiorini discusses PerformRx’s patient-driven approaches for addressing medication nonadherence in U.S. communities. With an amplified presence in their respective communities, he explained why pharmacists have the ability to truly tap into patient challenges and address them head-on with simple yet powerful conversations.

Expanding Immunization Access Through Pharmacy  
NCPA's Independent Rx Forum podcast highlights how pharmacy-provided immunization services have evolved, the critical role pharmacists play in vaccine access, and why these services continue to matter for public health. "Our goal has always been to make vaccines accessible and easy, so we try to reduce those barriers."

 

Better Adherence Lowers Payer Medical Costs  

Using administrative claims data from Optum’s de-identified Clinformatics® Data Mart Database, a research project between PQA, Merck, and the University of Mississippi examined Medicare Advantage enrollees who were taking either diabetes, renin-angiotensin system antagonist (RASA), or statin medications

Findings suggest the average patient-level adherence rate was between 84%-89% across the three medication classes using a modified version of the proportion of days covered (PDC) methodology.  More information about this project can be found through open access at BMC Health Services Research.

It is ever important to remember that applying quality measures to research, such as done in this project, often requires changes to the measure specifications to fit the research design. If you would like to discuss using PQA measures in your research, please contact [email protected].

 

Your Next Engagement Opportunities

Network, Learn and Collaborate with PQA

  •  PQA is accepting applications for the 2026-27 MPH Practicum program and Summer Executive Internship. Visit our student programs page to learn more.

  • Save the date for PQA's next Quality Forum Webinar on February 12, 20261-2 p.m. ET.

  • Save the date to join us at the 2026 PQA Annual Meeting, May 12-14, at the Hilton Baltimore Inner Harbor in Baltimore, Md. Submissions for poster abstract proposals are due Friday, January 16, 2026Learn more

Share this post:

Comments on "Five for Friday December 5: Celebrating Success in Advancing Medication Use Quality"

Comments 0-5 of 0

Please login to comment